Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Extension of SKY-0515 in Participants With Huntington's Disease Who Completed a Prior SKY-0515 Treatment Study

NCT07537075 is registered in ClinicalTrials.gov with Skyhawk Therapeutics, Inc. as lead sponsor.

NCT NCT07537075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07537075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Extension of SKY-0515 in Participants With Huntington's Disease Who Completed a Prior SKY-0515 Treatment Study
Lead sponsor
Skyhawk Therapeutics, Inc.
Phase
Phase 2/3
Overall status
Enrolling by invitation
Start date
April 10, 2026
Completion date
December 31, 2029
Enrollment
500 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

huntington's disease (hd)